News
12-13-2013, 06:03 AM
VG Life Sciences, a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.
More... (http://www.news-medical.net/news/20131213/VG-Life-Sciences-provides-update-to-HCQ-sorafenib-combination-Phase-I-Study-for-advanced-stage-solid-tumors.aspx)
More... (http://www.news-medical.net/news/20131213/VG-Life-Sciences-provides-update-to-HCQ-sorafenib-combination-Phase-I-Study-for-advanced-stage-solid-tumors.aspx)